Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Barbieri, M.D.

Title
Institution
Department
Address

Overview

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Barbieri JS, Beidas RS, Gondo GC, Fishman J, Williams NJ, Armstrong AW, Ogdie AR, Mehta N, Gelfand JM. Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease. JAMA Dermatol. 2022 Mar 01; 158(3):252-259. PMID: 35044419.
    Citations:    Fields:    
  2. Bommareddy K, Hamade H, Lopez-Olivo MA, Wehner M, Tosh T, Barbieri JS. Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Dermatol. 2022 Mar 01; 158(3):275-282. PMID: 35138351.
    Citations:    Fields:    
  3. Drake L, Reyes-Hadsall S, Barbieri JS, Mostaghimi A. New Developments in Topical Acne Therapy. Am J Clin Dermatol. 2022 Mar; 23(2):125-136. PMID: 35041198.
    Citations:    Fields:    
  4. Barbieri JS, Shinkai K. Introducing JAMA Network Insights in JAMA Dermatology. JAMA Dermatol. 2022 01 01; 158(1):15. PMID: 34851363.
    Citations:    Fields:    
  5. Berna R, Margolis DJ, Shin DB, Barbieri JS. Exploring the association between granuloma annulare and severity of type 2 diabetes in a large administrative database. J Am Acad Dermatol. 2021 Dec 30. PMID: 34973974.
    Citations:    Fields:    
  6. Horissian M, Maczuga S, Barbieri JS, Zaenglein AL. Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents. J Am Acad Dermatol. 2021 Dec 09. PMID: 34896127.
    Citations:    Fields:    
  7. Barbieri JS, Gelfand JM. Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis. JAMA Dermatol. 2021 10 01; 157(10):1236-1237. PMID: 34495286.
    Citations:    Fields:    
  8. Fathy R, Briker S, Rodriguez O, Barbieri JS. Comparing antibiotic prescription rates between in-person and telemedicine visits. J Am Acad Dermatol. 2021 Sep 06. PMID: 34499992.
    Citations:    Fields:    
  9. Barbieri JS, Fulton R, Neergaard R, Nelson MN, Barg FK, Margolis DJ. Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne: A Qualitative Study. JAMA Dermatol. 2021 09 01; 157(9):1040-1046. PMID: 34319378.
    Citations:    Fields:    
  10. Aizman L, Barbieri JS, Feit EM, Lukowiak TM, Perz AM, Shin TM, Miller CJ, Golda N, Leitenberger JJ, Carr DR, Nijhawan RI, Hasan A, Eisen DB, Etzkorn JR. Preferences for Prophylactic Oral Antibiotic Use in Dermatologic Surgery: A Multicenter Discrete Choice Experiment. Dermatol Surg. 2021 09 01; 47(9):1214-1219. PMID: 34081047.
    Citations:    Fields:    Translation:Humans
  11. Taylor MT, Keller M, Barbieri JS. Lifestyle risk factor counseling at visits for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2021 Aug 25. PMID: 34450204.
    Citations:    Fields:    
  12. Berna R, Margolis DJ, Barbieri JS. Attrition of topical calcineurin inhibitor use over time in patients with atopic dermatitis. J Am Acad Dermatol. 2021 Aug 11. PMID: 34390782.
    Citations:    Fields:    
  13. Ho T, Taylor MT, Marathe KS, Lucky AW, Barbieri JS. Most common pediatric skin conditions managed in outpatient dermatology clinics in the United States stratified by race and ethnicity. Pediatr Dermatol. 2021 Nov; 38 Suppl 2:129-131. PMID: 34339074.
    Citations:    Fields:    Translation:Humans
  14. Barbieri JS, Rosenbach M, Rodriguez O, Margolis DJ. Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms. JAMA Dermatol. 2021 07 01; 157(7):817-823. PMID: 34106218.
    Citations: 2     Fields:    
  15. Barbieri JS, Rodriguez O, Rosenbach M, Margolis D. Incidence and Prevalence of Granuloma Annulare in the United States. JAMA Dermatol. 2021 07 01; 157(7):824-830. PMID: 34106215.
    Citations: 2     Fields:    
  16. Barbieri JS, Drucker AM. The need for comparative effectiveness data to guide management of acne vulgaris. Br J Dermatol. 2021 09; 185(3):476-477. PMID: 34089193.
    Citations:    Fields:    Translation:Humans
  17. Barbieri JS, Rosenbach M, Rodriguez O, Margolis DJ. Granuloma annulare is not associated with solid-organ malignancies: A cohort study. J Am Acad Dermatol. 2021 May 11. PMID: 33984440.
    Citations: 1     Fields:    
  18. Miller J, Ly S, Mostaghimi A, Barbieri JS. Use of Active Comparator Trials for Topical Medications in Dermatology. JAMA Dermatol. 2021 05 01; 157(5):597-599. PMID: 33825805.
    Citations:    Fields:    Translation:Humans
  19. Barbieri JS, Bunya VY, Massaro-Giordano M, Margolis DJ. Encounters and medication use for ocular surface disorders among patients treated with dupilumab: A cohort study. JAAD Int. 2021 Sep; 4:1-9. PMID: 34409381.
    Citations:    
  20. Singh P, Brickley S, Richardson V, Barbieri JS. Comment on: "Skin biopsy and skin cancer treatment use in the Medicare population, 1993 to 2016". J Am Acad Dermatol. 2021 07; 85(1):e55-e56. PMID: 33771596.
    Citations:    Fields:    Translation:Humans
  21. Barbieri JS, Margolis DJ. Using cluster analysis to identify dermatologist and internist prescribing phenotypes for acne management. J Am Acad Dermatol. 2022 03; 86(3):679-681. PMID: 33667536.
    Citations:    Fields:    
  22. Barbieri JS, Margolis DJ, Mostaghimi A. Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone. JAMA Dermatol. 2021 03 01; 157(3):296-300. PMID: 33502462.
    Citations:    Fields:    Translation:Humans
  23. Desai S, Creadore A, Duncan LM, Lian CG, Yasuda MR, Mostaghimi A, Barbieri JS, Hartman RI. Comparison of Shave and Punch Biopsy Utilization Among Dermatology Practices. Cutis. 2021 Mar; 107(3):151-152. PMID: 33956608.
    Citations:    Fields:    Translation:Humans
  24. Barbieri JS, Chiesa Fuxench ZC, Shin DB, Takeshita J. Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis. Qual Life Res. 2021 Jun; 30(6):1705-1713. PMID: 33538979.
    Citations:    Fields:    Translation:Humans
  25. Petitt CE, Kiracofe E, Adamson A, Barbieri JS. Prior authorizations in dermatology and impact on patient care: An updated survey of US dermatology providers and staff by the American Academy of Dermatology. Dermatol Online J. 2021 Jan 15; 27(1). PMID: 33560787.
    Citations: 1     Fields:    Translation:Humans
  26. Garg V, Choi JK, James WD, Barbieri JS. Long-term use of spironolactone for acne in women: A case series of 403 patients. J Am Acad Dermatol. 2021 May; 84(5):1348-1355. PMID: 33434594.
    Citations: 1     Fields:    Translation:Humans
  27. Han JJ, Faletsky A, Barbieri JS, Mostaghimi A. New Acne Therapies and Updates on Use of Spironolactone and Isotretinoin: A Narrative Review. Dermatol Ther (Heidelb). 2021 Feb; 11(1):79-91. PMID: 33409936.
    Citations: 4     
  28. Taylor MT, Orenstein LAV, Barbieri JS. Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits. JAMA Dermatol. 2021 01 01; 157(1):115-117. PMID: 33206135.
    Citations: 1     Fields:    Translation:Humans
  29. Barbieri JS, Mostaghimi A, Noe MH, Margolis DJ, Gelfand JM. Use of primary care services among patients with chronic skin disease seen by dermatologists. JAAD Int. 2021 Mar; 2:31-36. PMID: 34409351.
    Citations: 1     
  30. Barbieri JS, Margolis DJ. Optimizing the Trial Design for a Comparative Effectiveness Study of Spironolactone versus Oral Antibiotics for Women With Acne: A Delphi Consensus Panel. J Drugs Dermatol. 2020 Dec 01; 19(12):1238-1239. PMID: 33346508.
    Citations:    Fields:    Translation:Humans
  31. Barbieri JS, Wang S, Ogdie AR, Shin DB, Takeshita J. Age-appropriate cancer screening: A cohort study of adults with psoriasis prescribed biologics, adults in the general population, and adults with hypertension. J Am Acad Dermatol. 2021 Jun; 84(6):1602-1609. PMID: 33470207.
    Citations: 1     Fields:    Translation:Humans
  32. Ho T, Barbieri JS, Housholder A, Fleischer AB. Trends in coal tar use in the United States. J Am Acad Dermatol. 2021 11; 85(5):1338-1339. PMID: 34229834.
    Citations:    Fields:    
  33. Taylor MT, Barbieri JS. Reply to "Depression screening for patients with acne in the United States compared to other skin diseases, 2005 to 2016". J Am Acad Dermatol. 2021 02; 84(2):e107. PMID: 33022306.
    Citations:    Fields:    Translation:Humans
  34. Barbieri JS, Tan JKL, Adamson AS. Active Comparator Trial Designs Used to Promote Development of Innovative New Medications. Cutis. 2020 Sep; 106(3):E4-E6. PMID: 33104125.
    Citations:    Fields:    Translation:Humans
  35. Barbieri JS. Diet and Acne-Challenges of Translating Nutritional Epidemiologic Research Into Clinical Practice. JAMA Dermatol. 2020 08 01; 156(8):841-843. PMID: 32520305.
    Citations: 1     Fields:    Translation:Humans
  36. Mostaghimi A, Adamson A, Barbieri J. Evaluation of the Merits and Limitations of Evidence-Based Medicine-Reply. JAMA Dermatol. 2020 08 01; 156(8):925-926. PMID: 32579166.
    Citations:    Fields:    Translation:Humans
  37. Nguyen HP, Barbieri JS, Albrecht J. Viability considerations in implementing same-class topical steroid substitution. J Am Acad Dermatol. 2020 12; 83(6):e441. PMID: 32738427.
    Citations:    Fields:    Translation:Humans
  38. Barbieri JS, Weiner DM, Kakpovbia E, Nagler AR. Validating the optimal classification approach using International Classification of Diseases, 10th Revision codes to identify dermatology patients with acne. J Am Acad Dermatol. 2021 May; 84(5):1491-1493. PMID: 32711090.
    Citations:    Fields:    Translation:Humans
  39. Barbieri JS. Isotretinoin and risk of inflammatory bowel disease: More data to support lack of meaningful risk. J Am Acad Dermatol. 2021 01; 84(1):228-229. PMID: 32682880.
    Citations:    Fields:    Translation:Humans
  40. Barbieri JS. New oral antifungals for onychomycosis: interesting potential and the need for comparative effectiveness trials. Br J Dermatol. 2021 02; 184(2):191. PMID: 32643171.
    Citations:    Fields:    Translation:Humans
  41. Fathy R, Nelson CA, Barbieri JS. Combating climate change in the clinic: Cost-effective strategies to decrease the carbon footprint of outpatient dermatologic practice. Int J Womens Dermatol. 2021 Jan; 7(1):107-111. PMID: 33537400.
    Citations: 1     
  42. Jew OS, Okawa J, Barbieri JS, McCaffrey J, Hayward E, Werth VP. Evaluating the effect of prior authorizations in patients with complex dermatologic conditions. J Am Acad Dermatol. 2020 Dec; 83(6):1674-1680. PMID: 32622138.
    Citations: 1     Fields:    Translation:Humans
  43. Barbieri JS, Fix WC, Miller CJ, Sobanko JF, Shin TM, Howe N, Margolis DJ, Etzkorn JR. Variation in Prescribing and Factors Associated With the Use of Prophylactic Antibiotics for Mohs Surgery: A Single-Institution Retrospective Study. Dermatol Surg. 2020 07; 46(7):868-875. PMID: 31577568.
    Citations:    Fields:    Translation:Humans
  44. Guzman AK, Barbieri JS. Comparative analysis of prescribing patterns of tetracycline class antibiotics and spironolactone between advanced practice providers and physicians in the treatment of acne vulgaris. J Am Acad Dermatol. 2021 Apr; 84(4):1119-1121. PMID: 32561369.
    Citations:    Fields:    Translation:Humans
  45. Guzman AK, Barbieri JS. Analysis of dermatology-related search engine trends during the COVID-19 pandemic: Implications for patient demand for outpatient services and telehealth. J Am Acad Dermatol. 2020 09; 83(3):963-965. PMID: 32505780.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  46. Barbieri JS, Chu B, Mostaghimi A. Sociodemographic Differences Associated with Utilization of Weekend Versus Weekday Primary Care Visits. J Gen Intern Med. 2021 07; 36(7):2180-2181. PMID: 32495090.
    Citations:    Fields:    Translation:Humans
  47. Barbieri JS, Mitra N, Margolis DJ, Harper CC, Mostaghimi A, Abuabara K. Influence of Contraception Class on Incidence and Severity of Acne Vulgaris. Obstet Gynecol. 2020 06; 135(6):1306-1312. PMID: 32459422.
    Citations:    Fields:    Translation:Humans
  48. Barbieri JS. A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne. JAMA Dermatol. 2020 06 01; 156(6):619-620. PMID: 32320045.
    Citations: 5     Fields:    Translation:Humans
  49. Chu B, Markeson CD, Barbieri JS. Association of air pollution and chronic inflammatory skin diseases: Challenges of Google Trends data and importance of local data. J Am Acad Dermatol. 2020 09; 83(3):e217-e218. PMID: 32434008.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  50. Nelson CA, Pérez-Chada LM, Creadore A, Li SJ, Lo K, Manjaly P, Pournamdari AB, Tkachenko E, Barbieri JS, Ko JM, Menon AV, Hartman RI, Mostaghimi A. Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study. JAMA Dermatol. 2020 05 01; 156(5):501-512. PMID: 32159733.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  51. Anshelevich EE, Barbieri JS, Kovarik CL. Intralesional cidofovir for treatment of recalcitrant warts in both immunocompetent and immunocompromised patients: A retrospective analysis of 58 patients. J Am Acad Dermatol. 2021 Jan; 84(1):206-207. PMID: 32348821.
    Citations: 2     Fields:    Translation:Humans
  52. Nguyen HP, Go JA, Barbieri JS, Stough D, Stoff BK, Forman HP, Bolognia JL, Albrecht J. Dissecting drug pricing: Supply chain, market, and nonmarket trends impacting clinical dermatology. J Am Acad Dermatol. 2020 08; 83(2):691-699. PMID: 32330637.
    Citations:    Fields:    Translation:Humans
  53. Guzman AK, Barbieri JS. Comment on "Dermatologists in social media: A study on top influencers, posts, and user engagement". J Am Acad Dermatol. 2022 02; 86(2):e49-e50. PMID: 32325108.
    Citations:    Fields:    
  54. Barbieri JS, Shin DB, Syed MN, Takeshita J, Gelfand JM. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis. JAMA Dermatol. 2020 04 01; 156(4):446-450. PMID: 32101261.
    Citations: 3     Fields:    Translation:Humans
  55. Bernardis E, Shou H, Barbieri JS, McMahon PJ, Perman MJ, Rola LA, Streicher JL, Treat JR, Castelo-Soccio L, Yan AC. Development and Initial Validation of a Multidimensional Acne Global Grading System Integrating Primary Lesions and Secondary Changes. JAMA Dermatol. 2020 03 01; 156(3):296-302. PMID: 31995147.
    Citations: 3     Fields:    Translation:Humans
  56. Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. Association of Race/Ethnicity and Sex With Differences in Health Care Use and Treatment for Acne. JAMA Dermatol. 2020 03 01; 156(3):312-319. PMID: 32022834.
    Citations: 2     Fields:    Translation:Humans
  57. Barbieri JS, Roe AH, Mostaghimi A. Simplifying contraception requirements for iPLEDGE: A decision analysis. J Am Acad Dermatol. 2020 Jul; 83(1):104-108. PMID: 32068040.
    Citations: 2     Fields:    Translation:Humans
  58. Singh P, Mostaghimi A, Barbieri JS. Antibiotic utilization in Medicare beneficiaries receiving Mohs micrographic surgery. J Am Acad Dermatol. 2020 Oct; 83(4):1184-1186. PMID: 32068038.
    Citations:    Fields:    Translation:Humans
  59. Wang RH, Barbieri JS, Nguyen HP, Stavert R, Forman HP, Bolognia JL, Kovarik CL. Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption? J Am Acad Dermatol. 2020 07; 83(1):299-307. PMID: 32035106.
    Citations: 11     Fields:    Translation:Humans
  60. Fathy R, Chu B, Singh P, James WD, Barbieri JS. Variation in Topical Antibiotics Recommendations in Wound Care Instructions by Non-dermatologists. J Gen Intern Med. 2021 01; 36(1):238-239. PMID: 32016704.
    Citations:    Fields:    Translation:Humans
  61. Taylor MT, Barbieri JS. Depression screening at visits for acne in the United States, 2005-2016. J Am Acad Dermatol. 2020 Sep; 83(3):936-938. PMID: 31972260.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  62. Fathy R, Chu B, James WD, Barbieri JS. The frequency of topical antibiotic use after biopsy and excision procedures among dermatologists and nondermatologists: 2006 through 2015. J Am Acad Dermatol. 2020 05; 82(5):1258-1261. PMID: 31927078.
    Citations: 1     Fields:    Translation:Humans
  63. Barbieri JS, Frieden IJ, Nagler AR. Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE. JAMA Dermatol. 2020 01 01; 156(1):21-22. PMID: 31664426.
    Citations: 4     Fields:    Translation:Humans
  64. Barbieri JS, Wehner MR. Systematic reviews in dermatology: opportunities for improvement. Br J Dermatol. 2020 06; 182(6):1329-1330. PMID: 31863474.
    Citations:    Fields:    Translation:Humans
  65. Pournamdari AB, Tkachenko E, Barbieri J, Adamson AS, Mostaghimi A. A State-of-the-Art Review Highlighting Medical Overuse in Dermatology, 2017-2018: A Systematic Review. JAMA Dermatol. 2019 12 01; 155(12):1410-1415. PMID: 31642872.
    Citations: 1     Fields:    Translation:Humans
  66. Lee MP, Sobanko JF, Shin TM, Howe NM, Barbieri JS, Miller CJ, Etzkorn JR. Evolution of Excisional Surgery Practices for Melanoma in the United States. JAMA Dermatol. 2019 Nov 01; 155(11):1244-1251. PMID: 31461124.
    Citations: 2     Fields:    
  67. Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A. Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017. JAMA Dermatol. 2019 Oct 01; 155(10):1162-1166. PMID: 31268488.
    Citations: 4     Fields:    
  68. Tkachenko E, Singer S, Sharma P, Barbieri J, Mostaghimi A. US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin. JAMA Dermatol. 2019 Oct 01; 155(10):1175-1179. PMID: 31314041.
    Citations: 8     Fields:    
  69. Stephens MR, Barbieri JS, Lipoff JB. Predicting future dermatology academic productivity from medical school publications. J Am Acad Dermatol. 2020 Aug; 83(2):624-626. PMID: 31499150.
    Citations: 3     Fields:    Translation:Humans
  70. Barbieri JS, Etzkorn JR, Margolis DJ. Preoperative Topical Decolonization-An Additional Strategy to Reduce Oral Antibiotic Prophylaxis for Mohs Infections?-Reply. JAMA Dermatol. 2019 09 01; 155(9):1089. PMID: 31389997.
    Citations:    Fields:    Translation:Humans
  71. Barbieri JS, Gelfand JM. Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A. Br J Dermatol. 2019 11; 181(5):1088-1090. PMID: 31102266.
    Citations: 1     Fields:    Translation:Humans
  72. Chu B, Fleischer A, Barbieri JS. The frequency of off-label prescribing in the treatment of dermatologic diseases during 2006-2015. J Am Acad Dermatol. 2020 02; 82(2):493-495. PMID: 31326467.
    Citations:    Fields:    Translation:Humans
  73. Tkachenko E, Singer SB, Sharma P, Barbieri J, Mostaghimi A. FDA Reports of Alopecia as an Adverse Event to Isotretinoin. J Cutan Med Surg. 2019 Jul/Aug; 23(4):451-452. PMID: 31337236.
    Citations: 4     Fields:    Translation:Humans
  74. Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2020 Jan; 82(1):72-79. PMID: 31228528.
    Citations: 7     Fields:    Translation:Humans
  75. Singh P, Barbieri JS. Frequency of dramatic price increases for topical medications, 2014-2018. J Am Acad Dermatol. 2019 12; 81(6):1429-1431. PMID: 31629619.
    Citations:    Fields:    
  76. Barbieri JS, Gelfand JM. Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States. JAMA Dermatol. 2019 06 01; 155(6):743-745. PMID: 30969312.
    Citations: 5     Fields:    Translation:Humans
  77. Barbieri JS, Etzkorn JR, Margolis DJ. Use of Antibiotics for Dermatologic Procedures From 2008 to 2016. JAMA Dermatol. 2019 04 01; 155(4):465-470. PMID: 30825412.
    Citations: 4     Fields:    Translation:Humans
  78. Barbieri JS, Choi JK, James WD, Margolis DJ. Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne. J Am Acad Dermatol. 2019 09; 81(3):848-851. PMID: 30905798.
    Citations: 2     Fields:    Translation:Humans
  79. Barbieri JS, St Claire K, Mostaghimi A, Albrecht J. Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology. JAMA Dermatol. 2019 03 01; 155(3):315-320. PMID: 30673082.
    Citations: 2     Fields:    Translation:Humans
  80. Barbieri JS, Bhate K, Hartnett KP, Fleming-Dutra KE, Margolis DJ. Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016. JAMA Dermatol. 2019 03 01; 155(3):290-297. PMID: 30649187.
    Citations: 12     Fields:    Translation:Humans
  81. Singh P, Forman H, Adamson AS, Mostaghimi A, Ogdie AR, Oganisian A, Barbieri JS. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries. J Gen Intern Med. 2019 02; 34(2):176-178. PMID: 30324292.
    Citations: 3     Fields:    Translation:Humans
  82. Barbieri JS, Gelfand JM. Evaluation of the Dermatology Life Quality Index scoring modification, the DLQI-R score, in two independent populations. Br J Dermatol. 2019 04; 180(4):939-940. PMID: 30430547.
    Citations: 5     Fields:    Translation:Humans
  83. Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol. 2019 Feb; 80(2):538-549. PMID: 30296534.
    Citations: 15     Fields:    Translation:Humans
  84. Yang X, Barbieri JS, Kovarik CL. Cost analysis of a store-and-forward teledermatology consult system in Philadelphia. J Am Acad Dermatol. 2019 Sep; 81(3):758-764. PMID: 30287316.
    Citations: 4     Fields:    Translation:Humans
  85. Barbieri JS, Yang X, Kovarik CL. Evaluating the cost-effectiveness of teledermatology. J Am Acad Dermatol. 2019 09; 81(3):765-766. PMID: 30287327.
    Citations: 1     Fields:    Translation:Humans
  86. Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2019 02; 80(2):577-578. PMID: 30244066.
    Citations: 3     Fields:    Translation:Humans
  87. Nelson CA, Kovarik CL, Barbieri JS. Human-computer symbiosis: enhancing dermatologic care while preserving the art of healing. Int J Dermatol. 2018 08; 57(8):1015-1016. PMID: 29873395.
    Citations: 1     Fields:    Translation:Humans
  88. Barbieri JS, Choi JK, Mitra N, Margolis DJ. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016. J Drugs Dermatol. 2018 Jun 01; 17(6):632-638. PMID: 29879250.
    Citations: 8     Fields:    Translation:Humans
  89. Ryskina KL, Goldberg E, Lott B, Hermann D, Barbieri JS, Lipoff JB. The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications. JAMA Dermatol. 2018 04 01; 154(4):456-459. PMID: 29490358.
    Citations: 5     Fields:    Translation:Humans
  90. Barbieri JS, Nguyen HP, Forman HP, Bolognia JL, Collins SAB. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Relative Value Scale Update Committee. J Am Acad Dermatol. 2018 04; 78(4):816-820. PMID: 29180092.
    Citations:    Fields:    
  91. Secrest AM, Asgari MM, Kourosh AS, Barbieri JS, Albrecht J. Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff. J Am Acad Dermatol. 2017 10; 77(4):784-786. PMID: 28917469.
    Citations: 1     Fields:    Translation:Humans
  92. Barbieri JS, Margolis DJ, Brod BA. Influence of Market Competition on Tetracycline Pricing and Impact of Price Increases on Clinician Prescribing Behavior. J Invest Dermatol. 2017 12; 137(12):2491-2496. PMID: 28842326.
    Citations: 4     Fields:    Translation:Humans
  93. Barbieri JS, James WD, Margolis DJ. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013. J Am Acad Dermatol. 2017 Sep; 77(3):456-463.e4. PMID: 28676330.
    Citations: 13     Fields:    Translation:Humans
  94. Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ. Commentary: Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015. J Am Acad Dermatol. 2017 06; 76(6):1203-1205. PMID: 28365041.
    Citations:    Fields:    Translation:Humans
  95. Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System. J Am Acad Dermatol. 2017 Jun; 76(6):1206-1212. PMID: 28365038.
    Citations:    Fields:    Translation:Humans
  96. Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ. Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology. J Am Acad Dermatol. 2017 Jun; 76(6):1213-1217. PMID: 28365040.
    Citations:    Fields:    Translation:Humans
  97. Nguyen HP, Barbieri JS, Forman HP, Bolognia JL, VanBeek MJ. Future considerations for clinical dermatology in the setting of 21st century American policy reform: Accountable Care Organizations. J Am Acad Dermatol. 2017 Jan; 76(1):170-176. PMID: 27707589.
    Citations:    Fields:    Translation:Humans
  98. Nguyen HP, Barbieri JS, Forman HP, Bolognia JL, VanBeek MJ. Introducing the Group for Research of Policy Dynamics in Dermatology: "Future considerations for clinical dermatology in the setting of 21st century American policy reform" manuscript series. J Am Acad Dermatol. 2017 Jan; 76(1):168-169. PMID: 27707592.
    Citations: 1     Fields:    Translation:Humans
  99. Barbieri JS, Hoffstad O, Margolis DJ. Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study. J Am Acad Dermatol. 2016 Dec; 75(6):1142-1150.e1. PMID: 27502311.
    Citations: 8     Fields:    Translation:Humans
  100. Barbieri JS, Nelson CA, James WD, Margolis DJ, Littman-Quinn R, Kovarik CL, Rosenbach M. The reliability of teledermatology to triage inpatient dermatology consultations. JAMA Dermatol. 2014 Apr; 150(4):419-24. PMID: 24522374.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  101. Nevadunsky NS, Barbieri JS, Kwong J, Merritt MA, Welch WR, Berkowitz RS, Mok SC. RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol. 2009 Feb; 112(2):325-30. PMID: 18937968.
    Citations: 22     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Barbieri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (262)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.